BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29028616)

  • 21. LC-MS/MS method for simultaneous determination of flavonoids and physalins in rat plasma: Application to pharmacokinetic study after oral administration of Physalis alkekengi var. franchetii (Chinese lantern) extract.
    Guo Y; Liu H; Ding L; Oppong M; Pan G; Qiu F
    Biomed Chromatogr; 2017 Oct; 31(10):. PubMed ID: 28273367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects.
    Hu Y; Wu J; Jiang X; Chen G; Zhang Y; Si L; Jiang H; Huang J; Huang J
    J Pharm Biomed Anal; 2022 Aug; 217():114826. PubMed ID: 35576735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
    Wang G; Wang H; Lin Z; Hou L; Wang JY; Sun L
    J Ethnopharmacol; 2022 Jan; 282():114560. PubMed ID: 34454053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An LC-MS/MS method for simultaneous determination of trantinterol and its major metabolite in rat plasma and its application to a comparative pharmacokinetic study.
    Wang Y; Qin F; Xiong Z; Fu X; Ma C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():163-8. PubMed ID: 26245359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a UPLC-MS/MS method for quantitation of metronidazole and 2-hydroxy metronidazole in human plasma and its application to a pharmacokinetic study.
    Stancil SL; van Haandel L; Abdel-Rahman S; Pearce RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():272-278. PubMed ID: 29933220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of BGT-002 and its acyl glucuronide metabolite ZM326E-M2 in human plasma by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study.
    Zhu X; Cui S; Liu X; Zhang M; Xie Z; Li W; Li J; Nan F; Zhang Y; Zhan Y; Chen X
    J Pharm Biomed Anal; 2024 Jun; 243():116056. PubMed ID: 38428245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
    Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of BPI15086 and its metabolite in human plasma by ultra-high performance liquid chromatography-MS/MS and its application to a pharmacokinetic study.
    Wang S; Zheng X; Zhang Y; Hu P; Ding L; Mao L; Jiang J
    Bioanalysis; 2019 Apr; 11(8):773-784. PubMed ID: 30994009
    [No Abstract]   [Full Text] [Related]  

  • 29. Liquid chromatography-tandem mass spectrometry method for simultaneous determination of seven commonly used anticancer drugs in human plasma.
    Zhou J; Gao S; Zhang F; Jiang B; Zhan Q; Cai F; Li J; Chen W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 906():1-8. PubMed ID: 22959676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Simultaneous determination of beauvericin and four enniatins in eggs by ultra-performance liquid chromatography-tandem mass spectrometry coupled with cold-induced liquid-liquid extraction and dispersive solid phase extraction].
    Liu B; Ni M; Shan X; Xie J; Dai Y; Zhang C
    Se Pu; 2021 Dec; 39(12):1331-1339. PubMed ID: 34812005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new simple method for quantification of cilostazol and its active metabolite in human plasma by LC-MS/MS: Application to pharmacokinetics of cilostazol associated with CYP genotypes in healthy Chinese population.
    Shen Y; Jiang B; Hu X; Chen J; Xu Y; Ruan Z; Yang D; Lou H
    Biomed Chromatogr; 2021 Oct; 35(10):e5150. PubMed ID: 33894005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a novel UPLC-MS/MS method for estimation of metformin and empagliflozin simultaneously in human plasma using freezing lipid precipitation approach and its application to pharmacokinetic study.
    Abou-Omar MN; Kenawy M; Youssef AO; Alharthi S; Attia MS; Mohamed EH
    J Pharm Biomed Anal; 2021 Jun; 200():114078. PubMed ID: 33901756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a UPLC-MS/MS method for quantification of C-005, a novel third-generation EGFR TKI, and its major metabolite in plasma: Application to its first-in-patient study.
    Wang Z; Ye W; Qin Y; You H; Zhang S; Fan F; Wang Y; Zheng L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122475. PubMed ID: 33370688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
    Rais R; Zhao M; He P; Xu L; Deeken JF; Rudek MA
    Biomed Chromatogr; 2012 Nov; 26(11):1315-24. PubMed ID: 22259028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous determination of dacomitinib and its major metabolite, O-desmethyl dacomitinib in human plasma by LC-MS/MS and its application to clinical testing in patients with non-small cell lung cancer.
    Feng X; Ding Y; Zhang P; Fu Q; Zhang L; Zheng H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122940. PubMed ID: 34564058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of henatinib in human plasma and urine by liquid chromatography-tandem mass spectrometry and its pharmacokinetic application.
    Qian J; Wang Y; Cao J; Li J
    J Pharm Biomed Anal; 2013 Jun; 80():173-9. PubMed ID: 23587531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of a sensitive simultaneous LC-MS/MS method for the quantification of novel anti-cancer thiazolidinedione and quinazolin-4-one derivatives in rat plasma and its application in a rat pharmacokinetic study.
    Sengottuvelan S; Uppal R; Vuppu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():18-27. PubMed ID: 31082683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of sulphasalazine and its main metabolite sulphapyridine and 5-aminosalicylic acid in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.
    Gu GZ; Xia HM; Pang ZQ; Liu ZY; Jiang XG; Chen J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(5-6):449-56. PubMed ID: 21251889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous determination of piperaquine and its N-oxidated metabolite in rat plasma using LC-MS/MS.
    Liu H; Zang M; Yang A; Ji J; Xing J
    Biomed Chromatogr; 2017 Oct; 31(10):. PubMed ID: 28299804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.